319 related articles for article (PubMed ID: 23271793)
1. Increased oxidative stress in the nucleus caused by Nox4 mediates oxidation of HDAC4 and cardiac hypertrophy.
Matsushima S; Kuroda J; Ago T; Zhai P; Park JY; Xie LH; Tian B; Sadoshima J
Circ Res; 2013 Feb; 112(4):651-63. PubMed ID: 23271793
[TBL] [Abstract][Full Text] [Related]
2. DPP (Dipeptidyl Peptidase)-4 Inhibitor Attenuates Ang II (Angiotensin II)-Induced Cardiac Hypertrophy via GLP (Glucagon-Like Peptide)-1-Dependent Suppression of Nox (Nicotinamide Adenine Dinucleotide Phosphate Oxidase) 4-HDAC (Histone Deacetylase) 4 Pathway.
Okabe K; Matsushima S; Ikeda S; Ikeda M; Ishikita A; Tadokoro T; Enzan N; Yamamoto T; Sada M; Deguchi H; Shinohara K; Ide T; Tsutsui H
Hypertension; 2020 Apr; 75(4):991-1001. PubMed ID: 32160098
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of Nox4 by hypertrophic stimuli promotes apoptosis and mitochondrial dysfunction in cardiac myocytes.
Ago T; Kuroda J; Pain J; Fu C; Li H; Sadoshima J
Circ Res; 2010 Apr; 106(7):1253-64. PubMed ID: 20185797
[TBL] [Abstract][Full Text] [Related]
4. Nobiletin, a Polymethoxy Flavonoid, Protects Against Cardiac Hypertrophy Induced by Pressure-Overload via Inhibition of NAPDH Oxidases and Endoplasmic Reticulum Stress.
Zhang N; Wei WY; Yang Z; Che Y; Jin YG; Liao HH; Wang SS; Deng W; Tang QZ
Cell Physiol Biochem; 2017; 42(4):1313-1325. PubMed ID: 28700997
[TBL] [Abstract][Full Text] [Related]
5. NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart.
Kuroda J; Ago T; Matsushima S; Zhai P; Schneider MD; Sadoshima J
Proc Natl Acad Sci U S A; 2010 Aug; 107(35):15565-70. PubMed ID: 20713697
[TBL] [Abstract][Full Text] [Related]
6. Nox2 and Nox4 mediate tumour necrosis factor-α-induced ventricular remodelling in mice.
Moe KT; Yin NO; Naylynn TM; Khairunnisa K; Wutyi MA; Gu Y; Atan MS; Wong MC; Koh TH; Wong P
J Cell Mol Med; 2011 Dec; 15(12):2601-13. PubMed ID: 21251215
[TBL] [Abstract][Full Text] [Related]
7. NOX2-dependent ROS is required for HDAC5 nuclear efflux and contributes to HDAC4 nuclear efflux during intense repetitive activity of fast skeletal muscle fibers.
Liu Y; Hernández-Ochoa EO; Randall WR; Schneider MF
Am J Physiol Cell Physiol; 2012 Aug; 303(3):C334-47. PubMed ID: 22648949
[TBL] [Abstract][Full Text] [Related]
8. Broad suppression of NADPH oxidase activity exacerbates ischemia/reperfusion injury through inadvertent downregulation of hypoxia-inducible factor-1α and upregulation of peroxisome proliferator-activated receptor-α.
Matsushima S; Kuroda J; Ago T; Zhai P; Ikeda Y; Oka S; Fong GH; Tian R; Sadoshima J
Circ Res; 2013 Apr; 112(8):1135-49. PubMed ID: 23476056
[TBL] [Abstract][Full Text] [Related]
9. Oxidation of HDAC4 by Nox4-derived H
Schader T; Löwe O; Reschke C; Malacarne P; Hahner F; Müller N; Gajos-Draus A; Backs J; Schröder K
Redox Biol; 2020 Sep; 36():101669. PubMed ID: 32818796
[TBL] [Abstract][Full Text] [Related]
10. Activation of NADPH oxidase 4 in the endoplasmic reticulum promotes cardiomyocyte autophagy and survival during energy stress through the protein kinase RNA-activated-like endoplasmic reticulum kinase/eukaryotic initiation factor 2α/activating transcription factor 4 pathway.
Sciarretta S; Zhai P; Shao D; Zablocki D; Nagarajan N; Terada LS; Volpe M; Sadoshima J
Circ Res; 2013 Nov; 113(11):1253-64. PubMed ID: 24081881
[TBL] [Abstract][Full Text] [Related]
11. NADPH oxidases in heart failure: poachers or gamekeepers?
Zhang M; Perino A; Ghigo A; Hirsch E; Shah AM
Antioxid Redox Signal; 2013 Mar; 18(9):1024-41. PubMed ID: 22747566
[TBL] [Abstract][Full Text] [Related]
12. Early NADPH oxidase-2 activation is crucial in phenylephrine-induced hypertrophy of H9c2 cells.
Hahn NE; Musters RJ; Fritz JM; Pagano PJ; Vonk AB; Paulus WJ; van Rossum AC; Meischl C; Niessen HW; Krijnen PA
Cell Signal; 2014 Sep; 26(9):1818-24. PubMed ID: 24794531
[TBL] [Abstract][Full Text] [Related]
13. Critical role of X-box binding protein 1 in NADPH oxidase 4-triggered cardiac hypertrophy is mediated by receptor interacting protein kinase 1.
Chen L; Zhao M; Li J; Wang Y; Bao Q; Wu S; Deng X; Tang X; Wu W; Liu X
Cell Cycle; 2017 Feb; 16(4):348-359. PubMed ID: 27929749
[TBL] [Abstract][Full Text] [Related]
14. Endothelial NADPH oxidase-2 promotes interstitial cardiac fibrosis and diastolic dysfunction through proinflammatory effects and endothelial-mesenchymal transition.
Murdoch CE; Chaubey S; Zeng L; Yu B; Ivetic A; Walker SJ; Vanhoutte D; Heymans S; Grieve DJ; Cave AC; Brewer AC; Zhang M; Shah AM
J Am Coll Cardiol; 2014 Jun; 63(24):2734-41. PubMed ID: 24681145
[TBL] [Abstract][Full Text] [Related]
15. A redox-dependent pathway for regulating class II HDACs and cardiac hypertrophy.
Ago T; Liu T; Zhai P; Chen W; Li H; Molkentin JD; Vatner SF; Sadoshima J
Cell; 2008 Jun; 133(6):978-93. PubMed ID: 18555775
[TBL] [Abstract][Full Text] [Related]
16. TGF-β
Guo W; Saito S; Sanchez CG; Zhuang Y; Gongora Rosero RE; Shan B; Luo F; Lasky JA
Am J Physiol Lung Cell Mol Physiol; 2017 Jun; 312(6):L936-L944. PubMed ID: 28336812
[TBL] [Abstract][Full Text] [Related]
17. Tyrosine kinase FYN negatively regulates NOX4 in cardiac remodeling.
Matsushima S; Kuroda J; Zhai P; Liu T; Ikeda S; Nagarajan N; Oka S; Yokota T; Kinugawa S; Hsu CP; Li H; Tsutsui H; Sadoshima J
J Clin Invest; 2016 Sep; 126(9):3403-16. PubMed ID: 27525436
[TBL] [Abstract][Full Text] [Related]
18. Nox4 and nox2 NADPH oxidases mediate distinct cellular redox signaling responses to agonist stimulation.
Anilkumar N; Weber R; Zhang M; Brewer A; Shah AM
Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1347-54. PubMed ID: 18467643
[TBL] [Abstract][Full Text] [Related]
19. Nicotinamide adenine dinucleotide phosphate oxidase-4-dependent upregulation of nuclear factor erythroid-derived 2-like 2 protects the heart during chronic pressure overload.
Smyrnias I; Zhang X; Zhang M; Murray TV; Brandes RP; Schröder K; Brewer AC; Shah AM
Hypertension; 2015 Mar; 65(3):547-53. PubMed ID: 25534702
[TBL] [Abstract][Full Text] [Related]
20. Involvement of Nox2 NADPH oxidase in adverse cardiac remodeling after myocardial infarction.
Looi YH; Grieve DJ; Siva A; Walker SJ; Anilkumar N; Cave AC; Marber M; Monaghan MJ; Shah AM
Hypertension; 2008 Feb; 51(2):319-25. PubMed ID: 18180403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
